Food News and Research

RSS

New book provides perspective on contributions made by nurses

The quiet actions of unsung heroes from the rainforest of Guatemala to the city streets of Harlem will be celebrated during the 2010 International Year of the Nurse in the new book, Giving through Teaching: How Nurse Educators are Changing the World (Springer Publishing).

14 Jun 2010

New bacterial strain could help in long-term cleanup of oil spills

Researchers have discovered a new strain of bacteria that can produce non-toxic, comparatively inexpensive "rhamnolipids," and effectively help degrade polycyclic aromatic hydrocarbons, or PAHs - environmental pollutants that are one of the most harmful aspects of oil spills.

14 Jun 2010

CAMD releases first combined clinical trial data on neuro-degenerative diseases

A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials will be released today by the Coalition Against Major Diseases (CAMD). This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.

14 Jun 2010

AIS introduces line of Full IP65/NEMA 4 Rated Stainless Steel LCD Computers for food industry

American Industrial Systems Inc., has introduced a line of Full IP65/NEMA 4 Rated Stainless Steel LCD Computers for superior performance in wet, dusty, rugged, and humid environments. The Panel PC utilizes the latest Intel® Atom Fanless processor featuring low power consumption, high reliability, long product life cycle and superior performance per watt operation.

14 Jun 2010

First step towards legally binding treaty to control mercury pollution completed at INC meeting

World governments, under the auspices of the United Nations Environment Programme, today completed the first step towards a legally binding treaty to control mercury pollution at the first Intergovernmental Negotiating Committee meeting, in Stockholm, Sweden. These initial discussions will provide a strong basis for developing the text of the treaty, starting at the next INC meeting in Tokyo, Japan, January 2011.

14 Jun 2010

Australian rainforests may provide potential cancer cure

Queensland scientists have discovered a drug to cure cancer that has effectively worked in animals and is to be tried on humans in the next phase of trials. This drug is plant-derived and is called EBC-46 for trial purposes. The plant from which it is obtained is found in the Australian tropical rainforest. The drug has shown to reduce inoperable tumors in 150 dogs, cats and horses and a ferret to a significant extent. The drug was developed over the past six years from the seed of a rainforest plant found in the Atherton Tablelands. Scientists had cultivated their own plantation of the plant since forming the company QBiotics Limited in 2004.

14 Jun 2010

FRC praises decision of federal Advisory Committee on Blood Safety and Availability

Family Research Council praised today's decision by the federal Advisory Committee on Blood Safety and Availability to reject any change in current blood donation rules. Current policy provides that men who have had sex with men at any time since 1977 are permanently "deferred" from acting as blood donors, because of the high rates of HIV infection in that population. The panel, which offers non-binding advice to the federal Department of Health and Human Services, voted 9-6 on Friday afternoon against recommending any immediate change in the policy.

14 Jun 2010

Opinions: Haitian housing; U.S. foreign aid

"The only thing that seems to be moving relentlessly ahead in Haiti is the weather, with punishing heat and near-daily thunderstorms settling in for the summer - and the hurricane season that just begun," according to a New York Times editorial highlighting some of the problems with the Haitian reconstruction effort.

14 Jun 2010

Children living in socially disadvantaged neighborhoods are more likely to be obese

Children in King County, Washington, are more likely to be obese if they live in socially disadvantaged neighborhoods. This is according to a team of researchers at Seattle Children's Research Institute, the University of Washington (UW), and Group Health Research Institute. Social Science & Medicine e-published the research this week in advance of printing it.

14 Jun 2010

Anti-infectives could circumvent the problem of antibiotic resistance

For a successful infection, bacteria must outwit the immune system of the host. To this aim, they deliver so-called virulence factors through a transport channel located in the bacterial membrane.

14 Jun 2010

FDA grants orphan drug designation for ICT-107

ImmunoCellular Therapeutics announced today that the U.S. Food and Drug Administration has granted orphan drug designation for ICT-107, the company's dendritic cell-based cancer vaccine candidate which targets glioblastoma multiforme. As a result of the orphan drug status, ImmunoCellular will be eligible to receive a number of benefits, including access to grant funding for clinical trials, tax credits, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of up to seven years.

11 Jun 2010

Gulf cleanup volunteers are putting themselves at risk of long-term health effects

With more oil from the BP spill in the Gulf washing ashore, regional communities will have a huge job of cleaning up after this vast environmental disaster. As kind-hearted volunteers participate in the effort to save both wildlife and the local environment, they will be putting themselves at risk of long-term health effects.

11 Jun 2010

Boston Scientific announces event schedule at 17th Cardiostim World Congress

Boston Scientific Corporation today announced the schedule of the Company's key events and sponsored research at the 17th Cardiostim World Congress, June 16 – 19 in Nice, France.

11 Jun 2010

Sundise to implement Medidata Rave as its EDC and CDM solution

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Traditional Chinese Medicine company Sundise will implement Medidata Rave as its electronic data capture and clinical data management solution. Selected for its ability to offer a broad global reach with local in-country support, Medidata will work with Sundise to conduct its first U.S. trial for its TCM treatment for liver fibrosis and will play a key role in supporting the company's strategy to launch in the U.S.

11 Jun 2010

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical has submitted its Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the company's unique polymer-free Zilver® PTX® Drug-Eluting Peripheral Stent. Intended for use in patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA), Zilver PTX is a self-expanding, highly durable nitinol stent that uses a proprietary, polymer-free technology to deliver a locally therapeutic dose of paclitaxel, an antiproliferative drug, to the target lesion.

11 Jun 2010

Uncork the Cure to contribute funds for children's brain tumor research

Uncork the Cure – a festival involving wine, food and music – will contribute funds for research into the causes of and cure for children's gliomas or brain tumors.

11 Jun 2010

BMS employees across Canada taking part in third annual Community Action Day

More than 300 employees of Bristol-Myers Squibb Canada will get the day off from their regular work today, but they won't be taking it easy. Instead, they will be joining company retirees and members of their own families in helping out at a variety of community and charitable organizations as part of the company's third annual BMS Community Action Day.

11 Jun 2010

CinGx safe and effective for treating diabetes, Alzheimer’s and dementia

There is currently no cure for Diabetes, Alzheimer's and Dementia but they can be treated and prevented. Allegiance Equity developed CinGx™ as a safe and effective treatment for these diseases.

11 Jun 2010

FRC supports new blood donation policy

Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.

11 Jun 2010

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Abraxis BioScience, Inc. presented trial design information from its ongoing phase 3 registration trial of nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension), in melanoma, an aggressive form of skin cancer that affects more than 68,000 people in the U.S. each year.

11 Jun 2010